Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: A cohort study.
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Question: Is broad-spectrum antibiotic use associated with poor outcomes in community-onset pneumonia after adjusting for confounders? Methods: We performed a retrospective, observational cohort study of 1995 adults with pneumonia admitted from four US hospital emergency departments. We used multivariable regressions to investigate the effect of broad-spectrum antibiotics on 30-day mortality, length of stay, cost and Clostridioides difficile infection (CDI). To address indication bias, we developed a propensity score using multilevel (individual provider) generalised linear mixed models to perform inverse-probability of treatment weighting (IPTW) to estimate the average treatment effect in the treated. We also manually reviewed a sample of mortality cases for antibiotic-associated adverse events. Results: 39.7% of patients received broad-spectrum antibiotics, but drug-resistant pathogens were recovered in only 3%. Broad-spectrum antibiotics were associated with increased mortality in both the unweighted multivariable model (OR 3.8, 95% CI 2.5–5.9; p<0.001) and IPTW analysis (OR 4.6, 95% CI 2.9–7.5; p<0.001). Broad-spectrum antibiotic use by either analysis was also associated with longer hospital stay, greater cost and increased CDI. Healthcare-associated pneumonia was not associated with mortality independent of broad-spectrum antibiotic use. In manual review we identified antibiotic-associated events in 17.5% of mortality cases. Conclusion: Broad-spectrum antibiotics appear to be associated with increased mortality and other poor outcomes in community-onset pneumonia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among undifferentiated patients with pneumonia or sepsis, broad-spectrum regimens including agents active against MRSA were associated with higher mortality, particularly among patients without MRSA [137, 151, 155, 156].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [156]
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Self-citation(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Austin, P. C., & Stuart, E. A. (2015) · Statistics in Medicine · doi:10.1002/sim.6607 · Cited by 4,495
Generalized Additive Models for Location Scale and Shape (GAMLSS) in R
Stasinopoulos, D. M., & Rigby, R. A. (2007) · Journal of Statistical Software · doi:10.18637/jss.v023.i07 · Cited by 1,560
Emergency Department Visits for Antibiotic‐Associated Adverse Events
Shehab, N., Patel, P. R., Srinivasan, A., & Budnitz, D. S. (2008) · Clinical Infectious Diseases · doi:10.1086/591126 · Cited by 535
Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012
Baggs, J., Fridkin, S. K., Pollack, L. A., Srinivasan, A., & Jernigan, J. A. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5651 · Cited by 268
Chalmers, J. D., Rother, C., Salih, W., & Ewig, S. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit734 · Cited by 251
Luther, M. K., Timbrook, T. T., Caffrey, A. R., Dosa, D., Lodise, T. P., & LaPlante, K. L. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002769 · Cited by 235
McCabe, C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.259 · Cited by 200
Risk of subsequent sepsis within 90 days after a hospital stay by type of antibiotic exposure.
Baggs, J., Jernigan, J. A., Halpin, A. L., Epstein, L., Hatfield, K. M., & McDonald, L. C. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix947 · Cited by 190
West, S. G., Cham, H., & Thoemmes, F. (2015) · The Encyclopedia of Clinical Psychology · doi:10.1002/9781118625392.wbecp505 · Cited by 182
Dangerfield, B., Chung, A., Webb, B., & Seville, M. T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01805-13 · Cited by 182
Self-citationGomes, D. M., Smotherman, C., Birch, A., Dupree, L., Della Vecchia, B. J., Kraemer, D. F., & Jankowski, C. A. (2014) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1428 · Cited by 180
Propensity score weighting analysis and treatment effect discovery
Mao, H., Li, L., & Greene, T. (2018) · Statistical Methods in Medical Research · doi:10.1177/0962280218781171 · Cited by 138
Hug, B. L., Witkowski, D. J., Sox, C. M., Keohane, C. A., Seger, D. L., Yoon, C. S., Matheny, M. E., & Bates, D. W. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1141-3 · Cited by 120
Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime
Rutter, W. C., Cox, J. N., Martin, C. A., Burgess, D. R., & Burgess, D. S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02089-16 · Cited by 116
Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
Attridge, R. T., Frei, C. R., Restrepo, M. I., Lawson, K. A., Ryan, L., Pugh, M. J. V., Anzueto, A., & Mortensen, E. M. (2011) · European Respiratory Journal · doi:10.1183/09031936.00141110 · Cited by 112
Dean, N. C., Jones, B. E., Jones, J. P., Ferraro, J. P., Post, H., Aronsky, D., Vines, C. G., Allen, T. L., & Haug, P. J. (2015) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2015.02.003 · Cited by 110
Self-citationAn update on adverse drug reactions related to β-lactam antibiotics
Vardakas, K. Z., Kalimeris, G. D., Triarides, N. A., & Falagas, M. E. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1462334 · Cited by 94
Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score
Webb, B. J., Dascomb, K. K., Stenehjem, E. A., Vikram, H. R., Agrwal, N., Sakata, K. K., Williams, K., Bockorny, B., Bagavathy, K., Mirza, S., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03071-15 · Cited by 87
Self-citationJones, B. E., Jones, M. M., Huttner, B., Stoddard, G., Brown, K. A., Stevens, V. W., Greene, T., Sauer, B., Madaras-Kelly, K., Rubin, M., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ629 · Cited by 84
CURB-65 Pneumonia Severity Assessment Adapted for Electronic Decision Support
Jones, B. E., Jones, J. P., Bewick, T. A., Lim, W. S., Aronsky, D., Brown, S. M., Boersma, W. G., van der Eerden, M. M., & Dean, N. C. (2010) · CHEST Journal · doi:10.1378/chest.10-1296 · Cited by 81
Self-citationRutter, W. C., Burgess, D. R., Talbert, J., & Burgess, D. S. (2017) · Journal of Hospital Medicine · doi:10.12788/jhm.2684 · Cited by 76
Mullins, B. P., Kramer, C. J., Bartel, B. J., Catlin, J., & Gilder, R. E. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018757497 · Cited by 71
Geller, A. I., Lovegrove, M. C., Shehab, N., Hicks, L. A., Sapiano, M. R. P., & Budnitz, D. S. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4430-x · Cited by 69
Rutter, W. C., & Burgess, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00264-18 · Cited by 58
Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression
Carrabba, M., Zarantonello, M., Bonara, P., Hu, C. M., Minonzio, F., Cortinovis, I., Milani, S., & Fabio, G. (2012) · European Respiratory Journal · doi:10.1183/09031936.00187811 · Cited by 56
Impact of Acute Kidney Injury in Patients Hospitalized With Pneumonia
Chawla, L. S., AMDUR, R. L., Faselis, C. J., Li, P., Kimmel, P. L., & Palant, C. E. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002245 · Cited by 55
Chalmers, J. D., Al-Khairalla, M., Short, P. M., Fardon, T. C., & Winter, J. H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq038 · Cited by 54
Sanz, F., Dean, N. C., Dickerson, J., Jones, B. E., Knox, D., Fernández‐Fabrellas, E., Chiner, E., Briones, M. L., Cervera, Á., Aguar, M. C., et al. (2015) · Respirology · doi:10.1111/resp.12560 · Cited by 49
Self-citationOutcomes of Patients with Healthcare-Associated Pneumonia: Worse Disease or Sicker Patients?
Rothberg, M. B., Haessler, S., Lagu, T. C., Lindenauer, P. K., Pekow, P. S., Priya, A., Skiest, D. J., & Zilberberg, M. D. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/677829 · Cited by 46
Incidence and impact of adverse effects to antibiotics in hospitalized adults with pneumonia
Lin, R. Y., Nuruzzaman, F., & Shah, S. N. (2009) · Journal of Hospital Medicine · doi:10.1002/jhm.414 · Cited by 44
Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia
Rothberg, M. B., Zilberberg, M. D., Pekow, P. S., Priya, A., Haessler, S., Belforti, R. K., Skiest, D. J., Lagu, T. C., Higgins, T. L., & Lindenauer, P. K. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku533 · Cited by 40
Malik, U., Armstrong, D., Ashworth, M., Dregan, A., L’Esperance, V., McDonnell, L., Molokhia, M., & White, P. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx374 · Cited by 39
Use of Tracheal Aspirate Culture in Newly Intubated Patients with Community-Onset Pneumonia
McCauley, L. M., Webb, B. J., Sorensen, J., & Dean, N. C. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201506-368bc · Cited by 24
Self-citationAnderson, C. W., Cazares, K., Lustik, M. B., Patel, S. M., & Denunzio, T. M. (2017) · Military Medicine · doi:10.7205/milmed-d-16-00197 · Cited by 14
Treatment Trends and Outcomes in Healthcare‐Associated Pneumonia
Haessler, S., Lagu, T. C., Lindenauer, P. K., Skiest, D. J., Priya, A., Pekow, P. S., Zilberberg, M. D., Higgins, T. L., & Rothberg, M. B. (2017) · Journal of Hospital Medicine · doi:10.12788/jhm.2877 · Cited by 13
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000298158.12101.41 · Cited by 9
Pneumonia and Clostridium difficile infection: Hospital acquired infection in a non-ICU department
Carrabba, M., Zarantonello, M., Formica, S., Mellace, L., Castaldi, S., Cappellini, M. D., & Fabio, G. (2012) · European Respiratory Journal · Cited by 8
Research works printed but not linked: 1
- Mecham ID, 2018, The association of qSOFA, SOFA and SIRSA with mortality in emergency department pneumonia patients, J Respir Infect, 97, e12634
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Rhee, C., Kadri, S. S., Dekker, J. P., Danner, R. L., Chen, H.-C., Fram, D., Zhang, F., Wang, R., Klompas, M., & Program, F. T. C. P. E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2899 · Cited by 397
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Martin-Loeches, I., Torres, A., Nagavci, B., Aliberti, S., Antonelli, M., Bassetti, M., Bos, L. D., Chalmers, J. D., Derde, L., de Waele, J., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-023-07033-8 · Cited by 316
“Logistics on how testing can be continuously available, and results reported, is a major implementation consideration.”
Aliberti, S., Dela Cruz, C. S., Amati, F., Sotgiu, G., & Restrepo, M. I. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00630-9 · Cited by 305
Metadata
- Authors
- Webb, B. J., Sorensen, J., Jephson, A., Mecham, I., & Dean, N. C.
- Affiliations
- Intermountain Healthcare (US)
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-04-25
- Volume
- 54
- Issue
- 1
- Pages
- 1900057
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2941945808
- Cited by
- 164
- References
- 40
- Citations by year
- 2026: 17 · 2025: 32 · 2024: 24 · 2023: 28 · 2022: 20 · 2021: 21 · 2020: 18 · 2019: 4
- FWCI
- 11.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Intermountain Research and Medical Foundation
- Topics
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- broad-spectrum antibiotics, community-onset pneumonia, 30-day mortality, Clostridium difficile infection, healthcare-associated pneumonia, length of hospital stay, health care costs, drug-resistant pathogens, emergency department admission, propensity score weighting
- MeSH terms
- Aged, Anti-Bacterial Agents, Clostridium Infections, Female, Humans, Length of Stay, Male, Middle Aged, Pneumonia, Retrospective Studies, Time Factors, Utah, Multivariate Analysis, Linear Models, Databases, Factual, Community-Acquired Infections, Drug Resistance, Bacterial, Propensity Score
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.